Looking for Hypromellose Phthalate pharmaceutical excipients? Find information on Hypromellose Phthalate's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDA Dossiers

read-more
read-more

01

Dosage Form : CAPSULE

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 48.1

Potency Unit : MG

blank

02

Dosage Form : CAPSULE, COATED PELLETS

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, COATED PELLETS

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 13.26

Potency Unit : MG

blank

03

Dosage Form : CAPSULE, DELAYED ACTION

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, DELAYED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 51.66

Potency Unit : MG

blank

04

Dosage Form : CAPSULE, DELAYED RELEASE

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, DELAYED RELEASE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 30

Potency Unit : MG

blank

05

Dosage Form : CAPSULE, ENTERIC COATED PELLET...

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, ENTERIC COATED PELLET...

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 144.51

Potency Unit : MG

blank

06

Dosage Form : CAPSULE, EXTENDED RELEASE

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, EXTENDED RELEASE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 46.66

Potency Unit : MG

blank

07

Dosage Form : CAPSULE, SUSTAINED ACTION

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, SUSTAINED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 19.63

Potency Unit : MG

blank

08

Dosage Form : GRANULE, FOR SUSPENSION

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : GRANULE, FOR SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 302.4

Potency Unit : MG

blank

09

Dosage Form : TABLET

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : TABLET

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 104.4

Potency Unit : MG

blank

10

Dosage Form : TABLET, DELAYED ACTION

HYPROMELLOSE PHTHALATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : TABLET, DELAYED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 9050311

UNII : NA

Potency Amount : 45.36

Potency Unit : MG

blank
click full view

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems Additives

read-more
read-more

Controlled Modified Release

read-more
read-more

MARKET PLACE

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty